Chemotherapy remains the principal mode of cancer treatment. Unfortunately, the """"""""intrinsic"""""""" and """"""""acquired"""""""" multidrug resistance (MDR) of cancer cells limits the success of chemotherapeutic treatment of cancers. """"""""Acquired"""""""" MDR indicates the fact that some cancers, such as breast, ovarian cancer, non-Hodgkin's lymphoma, adult acute leukemias and numerous childhood cancers, initially respond well to the chemotherapeutic treatment, but eventually become MDR during the treatment, reflecting different mechanisms from that of the """"""""intrinsic"""""""" MDR. Over-expression of P-glycoprotein, breast cancer resistant protein and/or multidrug resistance-associated protein (MRP1) confers """"""""acquired"""""""" MDR. Although all these ATP binding cassette (ABC) transporters transport anticancer drugs in an ATP dependent manner, different underlying mechanisms are involved. In addition, over-expression of these ABC transporters may not be the only reason to cause the """"""""acquired"""""""" MDR. For example, over-expression of MRP1 decreases drug accumulation inside a cancer cell and results in MDR, whereas over-expression of Bcl-2 alters apoptosis pathways and results in decreased sensitivity to anticancer drugs. Thus, there might not be a simple solution to solve the """"""""acquired"""""""" MDR caused by different mechanisms. A plausible strategy to reverse MDR is to understand the mechanism of each MDR, to treat each MDR individually and then to deal with MDR caused by multiple mechanisms globally. The objective proposed in this project is to elucidate the mechanism of ATP dependent solute transport by MRP1.
Specific aims i nvolved in this project are: 1. To test our hypothesis that ATP hydrolysis at NBD1 may not be essential for the ATP-dependent solute transport by MRP1; 2. To test whether or not the conformational changes induced by nucleotide binding at NBD1 and NBD2 are sufficient to transport the solute across the plasma membrane; 3. To test our hypothesis that nucleotide release from both NBDs facilitates the MRP1 protein to start a new cycle of ATP-dependent solute transport; 4. To determine the relationship between Km (ATP), Vmax (LTC4) and the drug resistance. New insights gained from these aims may provide the basis for novel means of combating MDR associated with over-expression of MRP1. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA089078-07
Application #
7218565
Study Section
Special Emphasis Panel (ZRG1-ONC-Q (01))
Program Officer
Forry, Suzanne L
Project Start
2001-01-01
Project End
2009-04-30
Budget Start
2007-05-01
Budget End
2008-04-30
Support Year
7
Fiscal Year
2007
Total Cost
$237,550
Indirect Cost
Name
Mayo Clinic, Arizona
Department
Type
DUNS #
153665211
City
Scottsdale
State
AZ
Country
United States
Zip Code
85259
Palaniyandi, Kanagaraj; Pockaj, Barbara A; Gendler, Sandra J et al. (2012) Human Breast Cancer Stem Cells Have Significantly Higher Rate of Clathrin-Independent and Caveolin-Independent Endocytosis than the Differentiated Breast Cancer Cells. J Cancer Sci Ther 4:214-222
Yang, Runying; Hou, Yue-xian; Campbell, Chase A et al. (2011) Glutamine residues in Q-loops of multidrug resistance protein MRP1 contribute to ATP binding via interaction with metal cofactor. Biochim Biophys Acta 1808:1790-6
Chang, Xiu-bao (2010) Molecular mechanism of ATP-dependent solute transport by multidrug resistance-associated protein 1. Methods Mol Biol 596:223-49
Hou, Yue-xian; Li, Chang-Zhong; Palaniyandi, Kanagaraj et al. (2009) Effects of putative catalytic base mutation E211Q on ABCG2-mediated methotrexate transport. Biochemistry 48:9122-31
Yang, Runying; Scavetta, Robert; Chang, Xiu-bao (2008) Interaction between the bound Mg.ATP and the Walker A serine residue in NBD2 of multidrug resistance-associated protein MRP1 plays a crucial role for the ATP-dependent leukotriene C4 transport. Biochemistry 47:8456-64
Yang, Runying; Scavetta, Robert; Chang, Xiu-Bao (2008) The hydroxyl group of S685 in Walker A motif and the carboxyl group of D792 in Walker B motif of NBD1 play a crucial role for multidrug resistance protein folding and function. Biochim Biophys Acta 1778:454-65
Perrotton, Thomas; Trompier, Doriane; Chang, Xiu-Bao et al. (2007) (R)- and (S)-verapamil differentially modulate the multidrug-resistant protein MRP1. J Biol Chem 282:31542-8
Yang, Runying; Chang, Xiu-bao (2007) Hydrogen-bond formation of the residue in H-loop of the nucleotide binding domain 2 with the ATP in this site and/or other residues of multidrug resistance protein MRP1 plays a crucial role during ATP-dependent solute transport. Biochim Biophys Acta 1768:324-35
Chang, Xiu-bao (2007) A molecular understanding of ATP-dependent solute transport by multidrug resistance-associated protein MRP1. Cancer Metastasis Rev 26:15-37
Buyse, Frederic; Hou, Yue-xian; Vigano, Catherine et al. (2006) Replacement of the positively charged Walker A lysine residue with a hydrophobic leucine residue and conformational alterations caused by this mutation in MRP1 impair ATP binding and hydrolysis. Biochem J 397:121-30

Showing the most recent 10 out of 16 publications